NEWRON PHARMACEUTICALS S.P.A.
Patent Owner
Stats
- 45 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Jan 02, 2018 most recent publication
Details
- 45 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 577 Total Citation Count
- Jan 25, 1991 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0029,365 PROCESS FOR THE PRODUCTION OF RALFINAMIDE SALTS SUBSTANTIALLY FREE FROM IMPURITIES HAVING GENOTOXIC EFFECTSOct 12, 16Feb 02, 17[C07C]
2016/0332,959 FLUORINATED ARYLALKYLAMINOCARBOXAMIDE DERIVATIVESJul 27, 16Nov 17, 16[A61K, C07D, C07C]
2010/0016,440 ALPHA-AMINOAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTSAug 20, 09Jan 21, 10[A61K, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9856207 Process for the production of ralfinamide salts substantially free from impurities having genotoxic effectsOct 12, 16Jan 02, 18[A61K, C07C]
9603832 Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Mar 28, 17[A61K, C07D, C07C, A61P]
9585869 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Mar 07, 17[A61K, C07D, C07C, A61P]
9505708 Process for the production of ralfinamide salts substantially free from impurities having genotoxic effectsApr 06, 11Nov 29, 16[A61K, C07C]
9474737 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Oct 25, 16[A61K, C07D, C07C, A61P]
9474738 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Oct 25, 16[A61K, C07D, C07C, A61P]
9474739 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsFeb 05, 15Oct 25, 16[A61K, C07D, C07C, A61P]
9248116 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulatorsMar 11, 13Feb 02, 16[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0184,068 USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORSAbandonedNov 04, 10Jul 28, 11[A61K, A61P]
2010/0267,835 Methods of treating disorders of trigeminalvascular activationAbandonedJan 15, 10Oct 21, 10[A61K, A61P]
2009/0005,436 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran DerivativesAbandonedFeb 22, 06Jan 01, 09[A61K, C07D, A61P]
2008/0096,965 (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective ModulatorsAbandonedJul 28, 05Apr 24, 08[A61K, A61P]
2007/0276,046 Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory AgentsAbandonedApr 22, 04Nov 29, 07[A61K]
2007/0112,025 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataractAbandonedMay 04, 04May 17, 07[A61K]
2006/0116,329 Halothenoyl-cyclopropane-1-carboxylic acid derivativesAbandonedNov 25, 03Jun 01, 06[A61K, C07D]
6303819 Substituted 2-benzylamino-2-phenyl-acetamide compoundsExpiredSep 11, 00Oct 16, 01[A61K, C07C]
5236957 N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparationExpiredJan 25, 91Aug 17, 93[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.